N-(1-acetyl-2,3-dihydroindol-5-yl)-N-(2-chloroprop-2-enyl)-2,2,2-trifluoroacetamide | 158942-45-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: N-(1-acetyl-2,3-dihydroindol-5-yl)-N-(2-chloroprop-2-enyl)-2,2,2-trifluoroacetamide
• CAS: 158942-45-1
• 化学式: C₁₅H₁₄ClF₃N₂O₂
• 分子量: 346.737
• InChiKey: JOEAOBGPHLYTDS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  23
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  40.6
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  N-(1-acetyl-2,3-dihydroindol-5-yl)-N-(2-chloroprop-2-enyl)-2,2,2-trifluoroacetamide 在 PPA 、 potassium carbonate 作用下， 以 甲醇 为溶剂， 反应 2.5h， 生成 1-(3-methyl-6,7-dihydro-1H-pyrrolo[2,3-f]indol-5-yl)ethanone
  参考文献：
  名称：

  Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists

  摘要：

  The synthesis and biological activity are reported for a series of analogues of the previously published indole urea 2 (SB-206553), designed to probe the 5-HT2C receptor binding site. Small molecule modeling studies have been used to define a region in space which is allowed at the 5-HT2C receptor but disallowed at the 5-HT2A receptor. In a complementary approach, docking of 2 into our model of the 5-HT2C receptor has allowed us to propose a novel primary binding interaction for this series of diaryl ureas, involving a potential double hydrogen-bonding interaction between the urea carbonyl oxygen of the ligand and two serine residues in the receptor. The difference of two valine residues in the 5-HT2C receptor for leucine residues in the 5-HT2A receptor is believed to account for the observed 5-HT2C/5-HT2A selectivity with 2.

  DOI：

  10.1021/jm960571v
• 作为产物：
  描述：

  1-乙酰基-5-氨基二氢吲哚 在 potassium carbonate 、 三乙胺 作用下， 以 氯仿 、 N,N-二甲基甲酰胺 为溶剂， 反应 17.0h， 生成 N-(1-acetyl-2,3-dihydroindol-5-yl)-N-(2-chloroprop-2-enyl)-2,2,2-trifluoroacetamide
  参考文献：
  名称：

  Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists

  摘要：

  The synthesis and biological activity are reported for a series of analogues of the previously published indole urea 2 (SB-206553), designed to probe the 5-HT2C receptor binding site. Small molecule modeling studies have been used to define a region in space which is allowed at the 5-HT2C receptor but disallowed at the 5-HT2A receptor. In a complementary approach, docking of 2 into our model of the 5-HT2C receptor has allowed us to propose a novel primary binding interaction for this series of diaryl ureas, involving a potential double hydrogen-bonding interaction between the urea carbonyl oxygen of the ligand and two serine residues in the receptor. The difference of two valine residues in the 5-HT2C receptor for leucine residues in the 5-HT2A receptor is believed to account for the observed 5-HT2C/5-HT2A selectivity with 2.

  DOI：

  10.1021/jm960571v

文献信息

• TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA
  申请人：STATENS SERUMINSTITUT

  公开号：EP0634927A1

  公开（公告）日：1995-01-25
• CONDENSED INDOLE DERIVATIVES AS 5HT 2C? AND 5HT 2B? ANTAGONISTS
  申请人：SMITHKLINE BEECHAM PLC

  公开号：EP0656003A1

  公开（公告）日：1995-06-07
• [EN] TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA
  申请人：STATENS SERUMINSTITUT

  公开号：WO1993017671A1

  公开（公告）日：1993-09-16

  (EN) Aromatic compounds, or prodrugs thereof, which contain an alkylating site and which are capable of alkylating the thiol group in N-acetyl-L-cysteine, in particular bis-aromatic $g(a),$g(b)-unsaturated ketones, are used for the preparation of pharmaceutical compositions or medicated feed, food or drinking water for the treatment or prophylaxis of diseases caused by microorganisms or parasites, in particular protozoa such as $i(Leishmania, Trypanosoma, Toxoplasma, Plasmodium, Pneumocystis, Babesia) and $i(Theileria), intestinal protozoa such as $i(Trichomonas) and $i(Ciardia; Coccidia) such as $i(Eimeria, Isospora, Cryptosporidium; Cappilaria, Microsporidium, Sarcocystis, Trichodina, Trichodinella, Dacthylogurus, Pseudodacthylogurus, Acantocephalus, Ichthylophtherius, Botrecephalus); and intracellular bacteria, in particular $i(Mycobacterium, Legionella) species, $i(Listeria) and $i(Salmonella). Preferred compounds have the formula (II): Xm-Ph-C(O)-CH=CH-Ph-Yn, wherein each phenyl group (Ph) may be mono- or polysubstituted; X and Y designate ARH or AZ, wherein A is O, S, NH or N(C1-6alkyl), RH designates aliphatic hydrocarbyl, and Z is H or a masking group which is decomposed to liberate AH; m is 0, 1 or 2, and n is 0, 1, 2 or 3, whereby, when m is 2, then the two X are the same or different, and when n is 2 or 3, then the two or three Y are the same or different, with the proviso that n and m are not both 0. As examples of such compounds, chalcones, e.g. licochalcone A (obtainable i.a. from batches of Chinese licorice root of Glycyrrhiza species, e.g. $i(G. uralensis) or $i(G. inflata)) as well as hydroxy, alk(en)yl, and/or alk(en)yloxy analogues thereof are active $i(in vitro) and/or $i(in vivo) against i.a. $i(L. major) and $i(P. falciparum).(FR) Composés aromatiques, ou pro-médicaments issus de ces composés, comportant un site d'alkylation et aptes à réaliser l'alkylation du groupe thiol dans la N-acétyl-L-cystéine, en particulier $g(a),$g(b)-cétones insaturées bisaromatiques, utilisés pour la production de préparations pharmaceutiques ou d'aliments médicamenteux, d'aliments ou d'eaux de boisson pour le traitement ou la prophylaxie de maladies causées par des microorganismes ou des parasites, en particulier par des protozoaires tels que $i(Leishmania, Trypanosoma, Toxoplasma, Plasmodium, Pneumocystis, Babesia) et $i(Theileria), par des protozoaires intestinaux tels que les $i(Trichomonas) et $i(Ciardia; Coccidia) tels que $i(Emeria, Isospora, Cryptosporidium, Cappilaria, Microsporidium, Sarcocystis, Trichodina, Trichodinella, Dacthylogurus, Pseudodacthylogurus, Acantocephalus, Ichthylophtherius, Botrecephalus); et des bactéries intracellulaires, notamment les espèces $i(Mycobacterium, Legionella, Listeria) et $i(Salmonella). Les composés préférés présentent la formule (II): Xm-Ph-C(O)-CH=CH-Ph-Yn, dans laquelle chacun des groupes phényle (pH) peut être mono ou polysubstitué; X et Y désignent ARH ou AZ, dans lequel A est O, S, NH ou N(C1-6alkyle), RH désigne un radical hydrocarbyle aliphatique, et Z est H ou un groupe écran qui est décomposé pour libérer AH; m est 0, 1 ou 2 et n est 0, 1, 2 ou 3, de telle sorte que, quand m est égal à 2, les deux X sont identiques ou différents, et lorsque n est égal à 2 ou 3, les deux ou trois Y sont identiques ou différents, pourvu que n et m ne soient pas tous les deux égaux à 0. Comme exemples de ces composés, on citera les chalcones, par exemple licochalcone A (pouvant être obtenu notamment à partir de racines de réglisse de l'espèce Glycyrrhiza, par exemple $i(G. uralensis) ou $i(G. inflata)) ainsi que leurs analogues hydroxy, alk(én)yle et/ou alk(én)yloxy, actifs $i(in vitro) et/ou $i(in vivo) contre notamment $i(L. major) et $i(P. falciparum).
• [EN] CONDENSED INDOLE DERIVATIVES AS 5HT2C AND 5HT2B ANTAGONISTS<br/>[FR] DERIVES D'INDOLE CONDENSES UTILISES COMME ANTAGONISTES DES RECEPTEURS 5HT2C et 5HT2B
  申请人：SMITHKLINE BEECHAM PLC

  公开号：WO1994004533A1

  公开（公告）日：1994-03-03

  (EN) Compounds of formula (I) or a salt thereof wherein: P represents a quinoline or isoquinoline residue, or a 5- or 6-membered aromatic heterocyclic ring containing up to three heteroatoms selected from nitrogen, oxygen or sulphur; R1 is hydrogen or C1-6 alkyl; R2, R3, R10 and R11 are independently hydrogen or C1-6 alkyl, or R10 and R11 together form a bond, or R2 and R10 or R3 and R11 together form a C2-6 alkylene chain; R4 is hydrogen, C1-6 alkyl, halogen, NR8R9 or OR12, where R8, R9 and R12 are independently hydrogen or C1-6 alkyl; R5 is hydrogen or C1-6 alkyl; R7 is hydrogen, C1-6 alkyl, OR12 or halogen, where R12 is hydrogen or C1-6 alkyl; n is 2 or 3; and the groups R13 and R14 are independently hydrogen or C1-6 alkyl, are 5HT2C/5HT2B receptor antagonists and are of potential use in the treatment of CNS disorders such as anxiety.(FR) Composés de formule (I) ou leur sel, formule dans laquelle P représente un résidu quinoléine ou isoquinoléine, ou bien un composé hétérocyclique aromatique pentagonal ou hexagonal renfermant jusqu'à 3 hétéroatomes choisis parmi azote, oxygène ou soufre; R1 est hydrogène ou alkyle C1-6; R2, R3, R10 et R11 sont indépendamment hydrogène ou alkyle C1-6, ou bien R10 et R11 forment ensemble une liaison, ou encore R2 et R10 ou R3 et R11 forment ensemble une chaîne alkylène C2-6; R4 est hydrogène, alkyle C1-6, halogène, NR8R9 ou OR12, où R8, R9 et R12 sont indépendamment hydrogène ou alkyle C1-6; R5 est hydrogène ou alkyle C1-6; R7 est hydrogène, alkyle C1-6, OR12 ou bien halogène, où R12 est hydrogène ou alkyle C1-6; n vaut 2 ou 3; et les groupes R13 et R14 sont indépendamment hydrogène ou alkyle C1-6. Ces composés sont des antagonistes des récepteurs 5HT2C/5HT2B et sont d'une utilisation potentielle dans le traitement des troubles du système nerveux central, tels que l'anxiété.
• Synthesis, Biological Activity, and Molecular Modeling Studies of Selective 5-HT_2C/2B Receptor Antagonists
  作者：Ian T. Forbes、Steven Dabbs、D. Malcolm Duckworth、Peter Ham、Graham E. Jones、Frank D. King、Damian V. Saunders、Frank E. Blaney、Christopher B. Naylor、Gordon S. Baxter、Thomas P. Blackburn、Guy A. Kennett、Martyn D. Wood

  DOI：10.1021/jm960571v

  日期：1996.1.1

  The synthesis and biological activity are reported for a series of analogues of the previously published indole urea 2 (SB-206553), designed to probe the 5-HT2C receptor binding site. Small molecule modeling studies have been used to define a region in space which is allowed at the 5-HT2C receptor but disallowed at the 5-HT2A receptor. In a complementary approach, docking of 2 into our model of the 5-HT2C receptor has allowed us to propose a novel primary binding interaction for this series of diaryl ureas, involving a potential double hydrogen-bonding interaction between the urea carbonyl oxygen of the ligand and two serine residues in the receptor. The difference of two valine residues in the 5-HT2C receptor for leucine residues in the 5-HT2A receptor is believed to account for the observed 5-HT2C/5-HT2A selectivity with 2.